News

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Variant NB.1.8.1 accounted for 0% of U.S. cases in April. By mid-June, it was estimated to be the cause of around 37% of ...